| For: | Désert R, Nieto N, Musso O. Dimensions of hepatocellular carcinoma phenotypic diversity. World J Gastroenterol 2018; 24(40): 4536-4547 [PMID: 30386103 DOI: 10.3748/wjg.v24.i40.4536] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i40/4536.htm |
| Number | Citing Articles |
| 1 |
Hung Huynh, Wai Har Ng. Reactivation of the PI3K/mTOR Signaling Pathway Confers Resistance to the FGFR4 Inhibitor FGF401. International Journal of Molecular Sciences 2025; 26(19) doi: 10.3390/ijms26199818
|
| 2 |
Natalia I. Krupenko, Jaspreet Sharma, Halle M. Fogle, Peter Pediaditakis, Kyle C. Strickland, Xiuxia Du, Kristi L. Helke, Susan Sumner, Sergey A. Krupenko. Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethylnitrosamine (DEN) Model of Liver Carcinogenesis. Cancers 2021; 13(13) doi: 10.3390/cancers13133219
|
| 3 |
Lise Desquilles, Luis Cano, Gevorg Ghukasyan, Nicolas Mouchet, Clémence Landreau, Anne Corlu, Bruno Clément, Bruno Turlin, Romain Désert, Orlando Musso. Well-differentiated liver cancers reveal the potential link between ACE2 dysfunction and metabolic breakdown. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-021-03710-0
|
| 4 |
Xianpeng Li, Huaixi Yu, Feng Xu, Yifeng Wu, Jifang Sheng, Kai Zheng. Differentially Expressed Long Noncoding RNAs Involved in FUBP1 Promoting Hepatocellular Carcinoma Cells Proliferation. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/6664519
|
| 5 |
Wai Har Ng, Khee Chee Soo, Hung Huynh. Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach. International Journal of Molecular Sciences 2024; 25(3) doi: 10.3390/ijms25031563
|
| 6 |
Vladimir M. Subbotin. A hypothesis on paradoxical privileged portal vein metastasis of hepatocellular carcinoma. Can organ evolution shed light on patterns of human pathology, and vice versa?. Medical Hypotheses 2019; 126 doi: 10.1016/j.mehy.2019.03.019
|
| 7 |
Maria Gonzalez, Javier Ruiz, Lucia Torres, Elena Ruiz. Synergistic Inhibition of Hepatocellular Carcinoma Growth via Combined mTOR Blockade and Microtubule Disruption. Bulletin of Pioneering Researches of Medical and Clinical Science 2025; 5(1) doi: 10.51847/3W32MQtXb8
|
| 8 |
Daniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, Matthias Ocker. Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets. World Journal of Gastroenterology 2019; 25(25): 3136-3150 doi: 10.3748/wjg.v25.i25.3136
|
| 9 |
Anna Gajos-Michniewicz, Malgorzata Czyz. WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. Genes & Diseases 2024; 11(2) doi: 10.1016/j.gendis.2023.02.050
|
| 10 |
Haruhiko Takeda, Atsushi Takai, Yuji Eso, Ken Takahashi, Hiroyuki Marusawa, Hiroshi Seno. Genetic Landscape of Multistep Hepatocarcinogenesis. Cancers 2022; 14(3) doi: 10.3390/cancers14030568
|
| 11 |
Satoyoshi Yamashita, Akira Kato, Toshitaka Akatsuka, Takashi Sawada, Tomohide Asai, Noriyuki Koyama, Kiwamu Okita. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(13): 1463-1473 doi: 10.3748/wjg.v26.i13.1463
|
| 12 |
Grant Tarnow, Rachel Matrenec, Claudia E. Oropeza, Mark Maienschein-Cline, Alan McLachlan. Distinct phenotypic spectra of hepatocellular carcinoma in liver-specific tumor suppressor-deficient hepatitis B virus transgenic mice. Virology 2022; 574 doi: 10.1016/j.virol.2022.08.002
|
| 13 |
Hung Huynh, Wai Har Ng, Khee Chee Soo. Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 25(1) doi: 10.3390/ijms25010017
|
| 14 |
Romain Desert, Xiaodong Ge, Zhuolun Song, Hui Han, Daniel Lantvit, Wei Chen, Sukanta Das, Dipti Athavale, Ioana Abraham‐Enachescu, Chuck Blajszczak, Yu Chen, Orlando Musso, Grace Guzman, Yujin Hoshida, Natalia Nieto. Role of Hepatocyte‐Derived Osteopontin in Liver Carcinogenesis. Hepatology Communications 2022; 6(4) doi: 10.1002/hep4.1845
|
| 15 |
Leiya Fu, Xinyu Gu, Na Lou, Juan Li, Chen Xue. Current research of the Notch pathway in hepatocellular carcinoma. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02626-z
|
| 16 |
Yoann Daniel, Elise Lelou, Caroline Aninat, Anne Corlu, Florian Cabillic. Interplay between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem Cells. Cancers 2021; 13(8) doi: 10.3390/cancers13081973
|
| 17 |
Evin Iscan, Umut Ekin, Gokhan Yildiz, Ozden Oz, Umur Keles, Aslı Suner, Gulcin Cakan-Akdogan, Gunes Ozhan, Marta Nekulova, Borivoj Vojtesek, Hamdiye Uzuner, Gökhan Karakülah, Hani Alotaibi, Mehmet Ozturk. TAp73β Can Promote Hepatocellular Carcinoma Dedifferentiation. Cancers 2021; 13(4) doi: 10.3390/cancers13040783
|
| 18 |
Claudia E. Oropeza, Caitlin R. Ondracek, Grant Tarnow, Mark Maienschein-Cline, Stefan J. Green, Alan McLachlan. Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patterns. Virology 2022; 566 doi: 10.1016/j.virol.2021.11.007
|
| 19 |
Srinivas Reddy Pallerla, Nghiem Xuan Hoan, Sivaramakrishna Rachakonda, Christian G. Meyer, Hoang Van Tong, Nguyen Linh Toan, Le Thi Kieu Linh, Dao Phuong Giang, Peter G. Kremsner, Mai Hong Bang, Le Huu Song, Thirumalaisamy P. Velavan. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01386-7
|
| 20 |
Yongling Chen, Ziqing Zhong, Xuelian Ruan, Xiuyu Zhan, Yanting Ding, Fangyi Wei, Xue Qin, Hongli Yu, Yu Lu. Novel biomarker in hepatocellular carcinoma: Stearoyl-CoA desaturase 1. Digestive and Liver Disease 2025; 57(3) doi: 10.1016/j.dld.2024.11.008
|
| 21 |
Guoming Deng, Yufeng Luo, Yaoming Zhang, Jinfeng Zhang, Zongyun He. Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathway. Bioengineered 2022; 13(2) doi: 10.1080/21655979.2021.2023983
|
| 22 |
Romain Desert, Wei Chen, Xiaodong Ge, Roselyne Viel, Hui Han, Dipti Athavale, Sukanta Das, Zhuolun Song, Daniel Lantvit, Luis Cano, Alexandra Naba, Orlando Musso, Natalia Nieto. Hepatocellular carcinomas, exhibiting intratumor fibrosis, express cancer-specific extracellular matrix remodeling and WNT/TGFB signatures, associated with poor outcome. Hepatology 2023; 78(3) doi: 10.1097/HEP.0000000000000362
|